Government Moves to Eliminate Redundant Viral Testing of Blood Products
Synopsis
The Indian government has released a draft proposal aimed at eliminating unnecessary viral testing of blood products, aligning regulations with international standards. This initiative seeks to streamline compliance and enhance patient safety. Public feedback is invited on the proposed changes.
Key Takeaways
Draft Notification: Proposes removal of redundant viral testing.
Regulatory Alignment: Aims to align with international pharmacopeial standards.
Public Feedback: Stakeholders invited to comment on the proposal.
Patient Safety: Focus remains on maintaining high safety standards.
Multiskilled Caregivers: Initiative to create 150,000 caregivers to meet domestic and global needs.
New Delhi, March 11 (NationPress) A draft Gazette Notification has been released by the government, suggesting modifications to eliminate redundant viral testing of blood products. Public feedback on this proposal is being encouraged, as stated in an official communication on Wednesday.
The proposed changes aim to align testing regulations for blood products with globally recognized pharmacopeial standards and to discard unnecessary testing protocols that conflict with international best practices, according to the Ministry of Health and Family Welfare.
The changes are recommended for "Para G (Testing of Blood Products), Part XII C, Schedule F of the Drugs Rules 1945".
The Ministry characterized this initiative as a significant move towards regulatory harmonization, a scientific rationalization of testing protocols, and a reduction of unnecessary compliance burdens while ensuring that patient safety remains a priority.
According to the harmonized standards outlined in the draft, the initial homogeneous pool of human plasma designated for fractionation must undergo testing for Hepatitis B surface antigen, Hepatitis C virus RNA, and antibodies to HIV. Pooled plasma must yield negative results for these viral markers prior to fractionation.
The draft specifies that only plasma pools that meet these safety standards should be utilized in the production of plasma-derived medicinal products.
Under the existing regulatory framework, final products manufactured from already tested and verified plasma pools undergo additional testing.
The new rules will eliminate repetitive testing, which currently occurs for the same viral markers at both the pooled plasma stage and the final product stage.
The statement urged stakeholders to examine the draft notification and provide their feedback and suggestions within the designated timeframe.
Recently, the government hosted a discussion session aimed at developing 150,000 "multiskilled caregivers" to address India’s growing domestic demands and to leverage emerging global opportunities within the care economy.
The Union Budget for 2026–27 has outlined a substantial initiative to enhance the care ecosystem through the introduction of NSQF-aligned training programs, which will integrate core caregiving competencies with supplementary skills, including wellness support, yoga, and the operation of medical and assistive devices.
aar/pk
Point of View
It is imperative to highlight the government's proactive approach in revising outdated testing protocols for blood products. By aligning with global standards, this initiative reflects a commitment to both patient safety and efficient healthcare practices, ultimately benefiting the public.
NationPress
2 Jul 2026
Frequently Asked Questions
What changes are being proposed in the draft Gazette Notification?
The government proposes to eliminate duplicate viral testing of blood products to align with international standards and reduce unnecessary compliance burdens.
Why is the government seeking public comments?
The government is inviting public feedback to ensure that stakeholders have a voice in shaping the final regulations.
What are the safety requirements for plasma pools?
Only plasma pools that test negative for Hepatitis B surface antigen, Hepatitis C virus RNA, and HIV antibodies can be used for manufacturing plasma-derived medicinal products.
How will these changes impact patient safety?
The amendments aim to maintain high safety standards while reducing unnecessary testing that does not contribute to patient safety.
What is the significance of the government's initiative to develop multiskilled caregivers?
The initiative aims to address India's growing domestic care needs and leverage global opportunities in the care economy.
